ERBB2 and cancer: Thus, HER2 positive cells may be potential progenitor cells of luminal A cells, and could be controlled, in principle, using the same therapeutic strategies as the luminal A subtype and eliminated if coupled with appropriate approach rewiring cancer cell stemness.